Obsidian Therapeutics, Inc (OBX) insider trading
Every open-market stock purchase and sale by Obsidian Therapeutics, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- No open-market insider trades in the last 12 months.
- No open-market insider buys on record.
Last 12 months: insiders bought $0 (0 buys) and sold $0 (0 sales). Last close $13.94 on Oct 22, 2026.
Recent OBX insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Aug 3, 2026 | Peter Barrett (Insider) | Bought (not open market) | — |
| Aug 3, 2026 | Robert W. Ross (Insider) | Bought (not open market) | — |
| Aug 3, 2026 | Matthew Norkunas (Insider) | Bought (not open market) | — |
| Aug 3, 2026 | Madan Jagasia (CEO) | Bought (not open market) | — |
| Aug 3, 2026 | Heidi Hagen (Insider) | Bought (not open market) | — |
| Aug 3, 2026 | Maria Fardis (Insider) | Bought (not open market) | — |
Who's trading OBX
- Peter Barrett, Insider: other filings, last Aug 3, 2026
- Maria Fardis, Insider: other filings, last Aug 3, 2026
- Heidi Hagen, Insider: other filings, last Aug 3, 2026
- Madan Jagasia, CEO: other filings, last Aug 3, 2026
- Matthew Norkunas, Insider: other filings, last Aug 3, 2026
- Robert W. Ross, Insider: other filings, last Aug 3, 2026
Get free alerts when an insider at Obsidian Therapeutics, Inc files a new trade →